Salesforce, Inc. (CRM)

Salesforce has pulled back into the middle of its range while its long-term trend holds up. The stock closed at $214.94 on November 9, 2026, up 0.60% on the session, but it is down 4.97% over one week and 6.19% over one month. It sits 9.95% below its 50-day average and 8.47% above its 200-day average, so the medium-term trend is mixed. The main question for investors is whether the strong August earnings beat, which lifted the shares 22.58% in the first session, can carry the stock back above its 50-day average, or whether the recent slide continues toward the 200-day average near $198.15.

Salesforce has beaten the EPS estimate in seven of its last eight reported quarters. The largest beat came with the August 26, 2026 report, when adjusted EPS of $5.90 compared with an estimate of $3.27, and the shares rose 22.58% in the first session after the report. Beats have not always produced gains: in four of the seven beats the share price fell in the first session. The stock's reaction to good numbers has therefore been uneven, and the August move is the exception rather than a steady pattern.

At a trailing P/E of 19.67, Salesforce trades at a discount to peers. The sector median P/E is 35.1, so the stock is 44.0% below it. Its price-to-sales ratio of 4.03 is also well under the sector median of 7.6. Trailing GAAP earnings per share of $10.93 support the multiple. The discount reflects that slower top line, and the profitability is what keeps the valuation from looking stretched.

Of 56 analysts with a current rating, 40 rate the stock buy or strong buy, 15 hold it and one sells it. Three months ago 40 of 55 ratings were buys, so the buy count has held steady. Among recent actions, B of A Securities upgraded the stock to Buy from Underperform on October 12, 2026, while DA Davidson kept a Neutral rating on October 21, 2026. Insiders sold $86.4M of stock over the last 18 months and bought $28.4M on the open market in six purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so the purchases are the more informative signal.

The base case is a stock that trades in a wide band between its 200-day average and its 20-day average while the market weighs fiscal-year growth against the slower top line. Analysts expect earnings per share to grow 33.8% this fiscal year, and revenue to rise 11.5%, so the earnings story is the main support. Analysts' median 12-month target of $285.00 sits 32.6% above the price, and the target range runs from $165.00 to $475.00. A better outcome would need the price to reclaim the 50-day average at $238.68 and hold it, with momentum improving from its current bearish reading. Analysts' estimates for next fiscal year call for EPS to shrink 4.4%, which is a risk if growth expectations reset.

Resistance sits first at the 20-day exponential moving average of $230.25, which the price has not yet reclaimed. The next resistance is the 50-day simple moving average at $238.68, followed by the 52-week high of $269.11. On the downside, the nearest support is the 200-day simple moving average at $198.15, which the price has held above. Below that, the 52-week low of $146.32 is the level a deeper decline would reach.